# Beyond statins, one drug lowered heart attack risk by 20%

> **Newsylist Open Intelligence Dossier** · First detected: 2026-11-06 14:29 UTC · Category: Business · Sources: 5 · Current Velocity: 2.8

## Intelligence Brief
"Beyond statins, one drug lowered heart attack risk by 20%" developed substantial multi-source reporting across the Business sector, tracked across 5 distinct newsrooms by Newsylist.


Key reporting was led by TipRanks, Patient Care Online, Yahoo and Amgen. Coverage velocity and cross-outlet momentum were measured using Newsylist open coverage telemetry.


Synthesized from multi-source international reporting and live coverage telemetry under Newsylist open intelligence methodology.

## Verified Facts & Key Claims
### What drove coverage for Beyond statins, one drug lowered heart attack risk by 20%?
Coverage spiked when 5 independent newsrooms published 5 verified reports during this coverage cycle.

### How did Newsylist track this trend?
Newsylist monitored article arrival rates, source diversity, and cross-outlet validation in real time.

## Multi-Source Evidence Table
| Source Outlet | Headline | Published (UTC) | Verification URL |
|---|---|---|---|
| TipRanks | Amgen’s Repatha lowers heart attack risk 20% vs. ezetimibe in real-world study | 2026-11-05 14:01 | [Source Link](https://news.google.com/rss/articles/CBMiwwFBVV95cUxOdDNfU0hsczdqUzhmbEdQakc5T3VPMDRsaldJRkRpY3dwTHVtSjZKYTZPUEZmazYxUGZySUpnd0xJLUg2RlRDcTE2TW56b0xrUWFxQzRpeGthamZwYS1zRHE5Q2Zra28zV244QVE2ZnlrWkRWZDIxdGloS2QzVmFxQkJOTTNscnNMeGlVdjRqcTZZYmpocEdqVUZ5a1dhbUMxLUt1MDItSXhNTFJ2TmVMUFR3b0s3bmpTbS1kaUlXSHBpTm8?oc=5) |
| Patient Care Online | Evolocumab Tied to 20% Lower Risk of Myocardial Infarction vs Ezetimibe in Real-World Study | 2026-11-05 14:01 | [Source Link](https://news.google.com/rss/articles/CBMiyAFBVV95cUxONGZRUUZva2ZBS2hNRGlOeXh0cDNjVXVMSUY4SG5Xa2V5TV8zRHJ2d1FDaERaS0RjTDIwWThpSlZJQlY0T245TGxnMWFwblNZdDQ3RVRtN3JwUWFUQUJBcUpsOFhYbkFtREZWMkV5dmlvU0h0V05SUFF4dVczQzZvVGtLdkh6QjJPaUMwVm1MLTVhbmZOMHAxazc5dHRkNlduemoweXplV0RyMTFWWXVrNi1UV0RjeDRjNnBMaTgzdVAzMnpwVUtQaA?oc=5) |
| Yahoo | Amgen’s Repatha reduces heart attack risk in real-world study | 2026-11-05 14:01 | [Source Link](https://news.google.com/rss/articles/CBMimAFBVV95cUxNdEdFRXktUWFwNEluNjltMzNkdWVBOVZVMHB3bDhlLUVEX0NlUktwMnI0RUl4N3kyaFBFZHZObElMYm9zNHEtZm1QaVJMaFIzM19jbnRCY1N0ZThVdHF3OFY4V2NSLUNSOGhlX1dOeWlUTE9JTWNUSU9zb3VkSkctYmFTRUdzZm5JZktRbEtmVTJBWG5zSElhaA?oc=5) |
| Amgen | REPATHA® LOWERS RISK OF HEART ATTACKS BY 20% COMPARED WITH EZETIMIBE IN A LARGE REAL-WORLD STUDY | 2026-11-05 14:01 | [Source Link](https://news.google.com/rss/articles/CBMi4AFBVV95cUxOVjNmSXBFRWRrVVlNdWJFX1FMS0s3SWtBSGhxTW1ka2wyY2hhNmJiZk8zcWdESHBkTmlka3g0R1NzeF9qUFRBZ0FrNzJDYVV5RkhuNXlGVEU1QjU0RDl3dlE0V1VIUlNhMEgwNnJrZkJjMGdCYXhSVUM5NURxUU1DUVdHQVJBQjdMTUswN3lJb1ZIaWY1OGhpOHBPUFNYWnFCcXU4SGxzVXhrb2Zha1R2Sld3eWlPQnNDMWVycjQ5QWxacEgxeU4tWlA3OEhJQWFnUENDU3pnN1k3elRkMm80cA?oc=5) |
| STAT | Beyond statins, one drug lowered heart attack risk by 20% | 2026-11-05 14:01 | [Source Link](https://news.google.com/rss/articles/CBMikwFBVV95cUxPdWpxMGRxWDlHSk0xUFdicFpQZDNMVlVFb0RUV1EtN0dJeERleFpiay1IWkVJU05ZelQzWjhFajBZTjZBV2syRE5FejI1NWVXRHlDNi1LZEVPX2ZoMm9rZ2t2eDFWU2VmUGVrTUg5LXY3NGZCXzNxdUxFMnAtTDBkUzV2dEVYUXlDemdGNnRWMWpOTzg?oc=5) |

---
*Canonical Source: https://www.newsylist.com/trend/2026-11-06/beyond-statins-one-drug-lowered-heart-attack-risk-by-20*
*Synthesized by Newsylist Open Intelligence Engine under E-E-A-T journalistic standards.*